BioXcel Therapeutics, Inc. is a biopharmaceutical company, which engages in the development of artificial intelligence solutions in neuroscience and immuno-oncology. It also focuses on utilizing technology and research to develop therapeutics solutions. The company was founded by Vimal D. Mehta on March 29, 2017 and is headquartered in New Haven, CT.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
29
Frequently Asked Questions
Market cap, also known as market capitalization, is the total market value of a company. It's calculated by multiplying the current market price by the total number of shares outstanding. BioXcel Therapeutics Inc market cap is $309,924.00.
52 week high is the highest price of a stock in the past 52 weeks, or one year. BioXcel Therapeutics Inc 52 week high is $2.33 as of November 22, 2026.
52 week low is the lowest price of a stock in the past 52 weeks, or one year. BioXcel Therapeutics Inc 52 week low is $0.0041 as of November 22, 2026.
BioXcel Therapeutics Inc stock price today is $0.0099.
BioXcel Therapeutics Inc stock price yesterday was $0.01.
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It's calculated by dividing a company's market capitalization by its book value. BioXcel Therapeutics Inc P/B ratio is -0.0027.
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It's calculated by averaging the closing stock price over the previous 50 trading days. BioXcel Therapeutics Inc 50-day moving average is $0.0294.